FDA has granted approval to US Antibiotics for the industrial manufacturing and distribution of pharmaceutical products, a move expected to expand the company's supply capabilities and support the domestic life sciences market. While the approval was initially granted in 1996, its recent implications point to the company’s strengthening position within the antibiotic and generic manufacturing sectors.